author-photo

Barbara Pender

Fred Hutchinson Cancer Research Center

16

Papers

1935

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Efficacy and Toxicity of CD19-Specific Chimeric Antigen Receptor T Cells Alone or in Combination with Ibrutinib for Relapsed and/or Refractory CLL

2019 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (7)
Comparison of Efficacy and Toxicity of CD19-Specific Chimeric Antigen Receptor T-Cells Alone or in Combination with Ibrutinib for Relapsed and/or Refractory CLL

2018 Blood
Show All
- Source
- Cite
- Save
Citations (36)
Factors impacting disease-free survival in adult B cell B-ALL patients achieving MRD-negative CR after CD19 CAR-T cells.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Factors associated with duration of response after CD19-specific CAR-T cell therapy for refractory/relapsed B-cell non-Hodgkin lymphoma.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
in adult B cell ALL patients

2016
Show All
- Source
- Cite
- Save
Citations (0)
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

2016 Journal of Clinical Investigation
Show All
- Source
- Cite
- Save
Citations (1068)
Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells

2016 Science Translational Medicine
Show All
- Source
- Cite
- Save
Citations (573)
Radioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remission

2016 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (6)
Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab.

2016 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (18)
Anti-CD19 Chimeric Antigen Receptor-Modified T Cell Therapy for B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Fludarabine and Cyclophosphamide Lymphodepletion Improves In Vivo Expansion and Persistence of CAR-T Cells and Clinical Outcomes

2015 Blood
Show All
- Source
- Cite
- Save
Citations (44)